Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share


Recent Breast Cancer News


Aromatase Inhibitor–Associated Joint Pain Tends to Resolve Upon Treatment Completion (November 15, 2016)

A class of drugs known as aromatase inhibitors (AI) commonly used in the management of estrogen receptor-positive (ER+) breast cancer are associated with troublesome joint pain. In fact, as many as half... Continue Reading

Ribociclib Offers ‘Paradigm Shift’ in Advanced Breast Cancer (October 26, 2016)

The investigational drug ribociclib (formerly LEE011) when combined with Femera (letrozole) for the initial treatment of postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer... Continue Reading

Metastatic Breast Cancer- Ask the Expert, Your Questions Answered (October 11, 2016)

Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD Dr. Dang discussed advances in the management of metastatic breast cancer and answered your questions in a live... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have... Continue Reading

MammaPrint Might Help Identify Breast Cancer Patients Who Could Safely Opt Out of Chemo (September 7, 2016)

MammaPrint, a 70-gene signature test, might help healthcare providers and patients determine whether they will derive a benefit from chemotherapy, or if they could safely choose to not receive chemotherapy... Continue Reading

ASCO Treatment Recommendations for HR+, Metastatic Breast Cancer (September 5, 2016)

The American Society of Clinical Oncology (ASCO) recently convened an Expert Panel to create recommendations for endocrine therapy for women with hormone-receptor (HR)-positive, metastatic breast cancer.... Continue Reading

Ribociclib Receives FDA Breakthrough Therapy Designation as First-line Treatment for HR+/HER2- Advanced Breast Cancer (August 3, 2016)

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ribociclib (LEE011) in combination with Femara® (letrozole) for the treatment of hormone receptor positive, human... Continue Reading

Neratinib Improves Cancer-Free Survival in Early Breast Cancer (July 27, 2016)

The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast... Continue Reading

West Los Angeles Premier Cancer Prevention 5K Celebrates 15 Years (July 5, 2016)

The Kickin’ Cancer!® 5K Run / Walk / Stroll is the Lynne Cohen Foundation’s flagship event to end women’s cancers through prevention. As a West Los Angeles favorite since 2001, this event celebrates... Continue Reading

Tecentriq™ Plus Abraxane® Effective Combo in Difficult to Treat Breast Cancer (June 30, 2016)

The combination of the immune stimulating agent Tecentriq™ (atezolizumab), plus the chemotherapy agent Abraxane® (nab-paclitaxel) is effective in providing anti-cancer responses among patients with... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS